Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 88 entries
Sorted by: Best Match Show Resources per page
Pre-harvest interventions to reduce carriage of E. coli O157 by harvest-ready feedlot cattle

Science interventions

Brashears MM.
GSID: QYdj32Bijw0J
GH Loneragan, MM Brashears - Meat Science, 2005 - Elsevier

… of pre-harvest interventions. This paper is not meant to serve as a clearinghouse for information on all potential interventions but rather, we will provide information on specific interventions that are … Focus has been placed on interventions that...

Cite
Loneragan, G. H., & Brashears, M. M. (2005). Pre-harvest interventions to reduce carriage of E. coli O157 by harvest-ready feedlot cattle. Meat Science, 71(1), 72-78.
Loneragan, G. H., and M. M. Brashears. "Pre-harvest interventions to reduce carriage of E. coli O157 by harvest-ready feedlot cattle." Meat Science 71.1 (2005): 72-78.
Copy Download .nbib Format: MLA
Delegating Discretion: Quasi Experiments on District Court Decision Making

quasi-experiments

Brashear L.
GSID: iV9M8co7-IsJ
L Brashear Tiede - American Politics Research, 2007 - journals.sagepub.com

… The case facts that I consider for my quasi experiments vary only as to whether the guideline ranges were applied or not. 26. I do separate tests for each year rather than grouping all of the cases together...

Cite
Brashear Tiede, L. (2007). Delegating Discretion: Quasi Experiments on District Court Decision Making. American Politics Research, 35(5), 595-620.
Brashear Tiede, Lydia. "Delegating Discretion: Quasi Experiments on District Court Decision Making." American Politics Research 35.5 (2007): 595-620.
Copy Download .nbib Format: MLA
Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health.

Journal of applied microbiology

Chaves BD, Brashears MM, Nightingale KK.
PMID: 28256040
J Appl Microbiol. 2017 Jul;123(1):18-28. doi: 10.1111/jam.13438. Epub 2017 May 03.

The goals of this review are to summarize the current knowledge on the application of Lactobacillus salivarius as a probiotic in animals and humans, and to address safety concerns with its use on live hosts. Overall, several strains of...

Cite
Chaves BD, Brashears MM, Nightingale KK. Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health. J Appl Microbiol. 2017;123(1):18-28doi: 10.1111/jam.13438.
Chaves, B. D., Brashears, M. M., & Nightingale, K. K. (2017). Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health. Journal of applied microbiology, 123(1), 18-28. https://doi.org/10.1111/jam.13438
Chaves, B D, et al. "Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health." Journal of applied microbiology vol. 123,1 (2017): 18-28. doi: https://doi.org/10.1111/jam.13438
Chaves BD, Brashears MM, Nightingale KK. Applications and safety considerations of Lactobacillus salivarius as a probiotic in animal and human health. J Appl Microbiol. 2017 Jul;123(1):18-28. doi: 10.1111/jam.13438. Epub 2017 May 03. PMID: 28256040.
Copy Download .nbib Format: NLM
Frontal Release Signs and Their Relationship With the Initiation and Perseveration Component of the Mattis Dementia Rating Scale in Persons With Dementia.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

Vieweg WVR, Brashear HR, Sautter SW, Tabscott JA.
PMID: 28530909
Am J Geriatr Psychiatry. 1993 Autumn;1(4):310-315. doi: 10.1097/00019442-199300140-00005. Epub 2013 Jan 28.

As part of a longitudinal study of dementia, 35 elderly patients with dementia were studied, correlating frontal release signs and performance on components of the Mattis Dementia Rating Scale. A frontal release score was developed using glabellar, palmar grasp,...

Cite
Vieweg WVR, Brashear HR, Sautter SW, et al. Frontal Release Signs and Their Relationship With the Initiation and Perseveration Component of the Mattis Dementia Rating Scale in Persons With Dementia. Am J Geriatr Psychiatry. 2013;1(4):310-315doi: 10.1097/00019442-199300140-00005.
Vieweg, W. V. R., Brashear, H. R., Sautter, S. W., & Tabscott, J. A. (1993). Frontal Release Signs and Their Relationship With the Initiation and Perseveration Component of the Mattis Dementia Rating Scale in Persons With Dementia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1(4), 310-315. https://doi.org/10.1097/00019442-199300140-00005
Vieweg, W Victor R, et al. "Frontal Release Signs and Their Relationship With the Initiation and Perseveration Component of the Mattis Dementia Rating Scale in Persons With Dementia." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry vol. 1,4 (1993): 310-315. doi: https://doi.org/10.1097/00019442-199300140-00005
Vieweg WVR, Brashear HR, Sautter SW, Tabscott JA. Frontal Release Signs and Their Relationship With the Initiation and Perseveration Component of the Mattis Dementia Rating Scale in Persons With Dementia. Am J Geriatr Psychiatry. 1993 Autumn;1(4):310-315. doi: 10.1097/00019442-199300140-00005. Epub 2013 Jan 28. PMID: 28530909.
Copy Download .nbib Format: NLM
Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials.

Alzheimer's & dementia (New York, N. Y.)

Xu SX, Samtani MN, Russu A, Adedokun OJ, Lu M, Ito K, Corrigan B, Raje S, Brashear HR, Styren S, Hu C.
PMID: 29854934
Alzheimers Dement (N Y). 2015 Jul 21;1(2):141-149. doi: 10.1016/j.trci.2015.06.005. eCollection 2015 Sep.

OBJECTIVE: Disability assessment for dementia (DAD) measurements from two phase-3 studies of bapineuzumab in METHODS: We evaluated longitudinal changes in DAD scores, baseline factors affecting disease progression, and bapineuzumab effect on disease progression.RESULTS: A beta regression model best described...

Cite
Xu SX, Samtani MN, Russu A, et al. Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Alzheimers Dement (N Y). 2015;1(2):141-149doi: 10.1016/j.trci.2015.06.005.
Xu, S. X., Samtani, M. N., Russu, A., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Brashear, H. R., Styren, S., & Hu, C. (2015). Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Alzheimer's & dementia (New York, N. Y.), 1(2), 141-149. https://doi.org/10.1016/j.trci.2015.06.005
Xu, Steven X, et al. "Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials." Alzheimer's & dementia (New York, N. Y.) vol. 1,2 (2015): 141-149. doi: https://doi.org/10.1016/j.trci.2015.06.005
Xu SX, Samtani MN, Russu A, Adedokun OJ, Lu M, Ito K, Corrigan B, Raje S, Brashear HR, Styren S, Hu C. Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Alzheimers Dement (N Y). 2015 Jul 21;1(2):141-149. doi: 10.1016/j.trci.2015.06.005. eCollection 2015 Sep. PMID: 29854934; PMCID: PMC5975025.
Copy Download .nbib Format: NLM
Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab.

Alzheimer's & dementia (New York, N. Y.)

Samtani MN, Xu SX, Russu A, Adedokun OJ, Lu M, Ito K, Corrigan B, Raje S, Brashear HR, Styren S, Hu C.
PMID: 29854935
Alzheimers Dement (N Y). 2015 Oct 09;1(3):157-169. doi: 10.1016/j.trci.2015.09.001. eCollection 2015 Nov.

INTRODUCTION: The objective of this study was to estimate longitudinal changes in disease progression (measured by Alzheimer's disease assessment scale-cognitive 11-item [ADAS-cog/11] scale) after bapineuzumab treatment and to identify covariates (demographics or baseline characteristics) contributing to the variability in...

Cite
Samtani MN, Xu SX, Russu A, et al. Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab. Alzheimers Dement (N Y). 2015;1(3):157-169doi: 10.1016/j.trci.2015.09.001.
Samtani, M. N., Xu, S. X., Russu, A., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Brashear, H. R., Styren, S., & Hu, C. (2015). Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab. Alzheimer's & dementia (New York, N. Y.), 1(3), 157-169. https://doi.org/10.1016/j.trci.2015.09.001
Samtani, Mahesh N, et al. "Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab." Alzheimer's & dementia (New York, N. Y.) vol. 1,3 (2015): 157-169. doi: https://doi.org/10.1016/j.trci.2015.09.001
Samtani MN, Xu SX, Russu A, Adedokun OJ, Lu M, Ito K, Corrigan B, Raje S, Brashear HR, Styren S, Hu C. Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab. Alzheimers Dement (N Y). 2015 Oct 09;1(3):157-169. doi: 10.1016/j.trci.2015.09.001. eCollection 2015 Nov. PMID: 29854935; PMCID: PMC5975060.
Copy Download .nbib Format: NLM
Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)

Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, Graf A, Martenyi F, Storck MS, Randolph C.
PMID: 29955653
Alzheimers Dement (N Y). 2018 Feb 13;4:64-75. doi: 10.1016/j.trci.2018.01.003. eCollection 2018.

The Alzheimer's Association's Research Roundtable met in November 2016 to explore how best to measure changes in cognition and function in the preclinical stage of Alzheimer's disease. This review will cover the tools and instruments currently available to identify...

Cite
Weintraub S, Carrillo MC, Farias ST, et al. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:64-75doi: 10.1016/j.trci.2018.01.003.
Weintraub, S., Carrillo, M. C., Farias, S. T., Goldberg, T. E., Hendrix, J. A., Jaeger, J., Knopman, D. S., Langbaum, J. B., Park, D. C., Ropacki, M. T., Sikkes, S. A. M., Welsh-Bohmer, K. A., Bain, L. J., Brashear, R., Budur, K., Graf, A., Martenyi, F., Storck, M. S., & Randolph, C. (2018). Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 464-75. https://doi.org/10.1016/j.trci.2018.01.003
Weintraub, Sandra, et al. "Measuring cognition and function in the preclinical stage of Alzheimer's disease." Alzheimer's & dementia (New York, N. Y.) vol. 4 (2018): 64-75. doi: https://doi.org/10.1016/j.trci.2018.01.003
Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, Knopman DS, Langbaum JB, Park DC, Ropacki MT, Sikkes SAM, Welsh-Bohmer KA, Bain LJ, Brashear R, Budur K, Graf A, Martenyi F, Storck MS, Randolph C. Measuring cognition and function in the preclinical stage of Alzheimer's disease. Alzheimers Dement (N Y). 2018 Feb 13;4:64-75. doi: 10.1016/j.trci.2018.01.003. eCollection 2018. PMID: 29955653; PMCID: PMC6021264.
Copy Download .nbib Format: NLM
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.

Movement disorders clinical practice

Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C.
PMID: 30009213
Mov Disord Clin Pract. 2018 Apr 26;5(3):273-282. doi: 10.1002/mdc3.12613. eCollection 2018.

BACKGROUND: Injectable daxibotulinumtoxinA (an investigational botulinum toxin, RT002) may offer a more prolonged duration of response-and therefore less frequent dosing-than onabotulinumtoxinA.OBJECTIVES: To perform a phase 2, open-label, dose-escalation study to assess the efficacy and safety of daxibotulinumtoxinA in cervical...

Cite
Jankovic J, Truong D, Patel AT, et al. Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Mov Disord Clin Pract. 2018;5(3):273-282doi: 10.1002/mdc3.12613.
Jankovic, J., Truong, D., Patel, A. T., Brashear, A., Evatt, M., Rubio, R. G., Oh, C. K., Snyder, D., Shears, G., & Comella, C. (2018). Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Movement disorders clinical practice, 5(3), 273-282. https://doi.org/10.1002/mdc3.12613
Jankovic, Joseph, et al. "Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study." Movement disorders clinical practice vol. 5,3 (2018): 273-282. doi: https://doi.org/10.1002/mdc3.12613
Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C. Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Mov Disord Clin Pract. 2018 Apr 26;5(3):273-282. doi: 10.1002/mdc3.12613. eCollection 2018. PMID: 30009213; PMCID: PMC6032882.
Copy Download .nbib Format: NLM
Cross-indexed file for medical literature.

Annals of internal medicine

Baker DH, Brashear RH.
PMID: 4621088
Ann Intern Med. 1974 Apr;80(4):557-9. doi: 10.7326/0003-4819-80-4-557.

No abstract available.

Cite
Baker DH, Brashear RH. Cross-indexed file for medical literature. Ann Intern Med. 1974;80(4):557-9doi: 10.7326/0003-4819-80-4-557.
Baker, D. H., & Brashear, R. H. (1974). Cross-indexed file for medical literature. Annals of internal medicine, 80(4), 557-9. https://doi.org/10.7326/0003-4819-80-4-557
Baker, D H, and Brashear, R H. "Cross-indexed file for medical literature." Annals of internal medicine vol. 80,4 (1974): 557-9. doi: https://doi.org/10.7326/0003-4819-80-4-557
Baker DH, Brashear RH. Cross-indexed file for medical literature. Ann Intern Med. 1974 Apr;80(4):557-9. doi: 10.7326/0003-4819-80-4-557. PMID: 4621088.
Copy Download .nbib Format: NLM
New .

Frontiers in microbiology

Brashear AM, Huckaby AC, Fan Q, Dillard LJ, Hu Y, Li Y, Zhao Y, Wang Z, Cao Y, Miao J, Guler JL, Cui L.
PMID: 32849480
Front Microbiol. 2020 Aug 11;11:1930. doi: 10.3389/fmicb.2020.01930. eCollection 2020.

No abstract available.

Cite
Brashear AM, Huckaby AC, Fan Q, et al. New . Front Microbiol. 2020;11:1930doi: 10.3389/fmicb.2020.01930.
Brashear, A. M., Huckaby, A. C., Fan, Q., Dillard, L. J., Hu, Y., Li, Y., Zhao, Y., Wang, Z., Cao, Y., Miao, J., Guler, J. L., & Cui, L. (2020). New . Frontiers in microbiology, 111930. https://doi.org/10.3389/fmicb.2020.01930
Brashear, Awtum M, et al. "New ." Frontiers in microbiology vol. 11 (2020): 1930. doi: https://doi.org/10.3389/fmicb.2020.01930
Brashear AM, Huckaby AC, Fan Q, Dillard LJ, Hu Y, Li Y, Zhao Y, Wang Z, Cao Y, Miao J, Guler JL, Cui L. New . Front Microbiol. 2020 Aug 11;11:1930. doi: 10.3389/fmicb.2020.01930. eCollection 2020. PMID: 32849480; PMCID: PMC7432439.
Copy Download .nbib Format: NLM
Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants.

The American journal of tropical medicine and hygiene

Neuman BW, Brashear WA, Brun M, Chaki SP, Fischer RSB, Guidry SJ, Hill JE, Hillhouse AE, Johnson CD, Kahl-McDonagh MM, Metz RP, Rice-Ficht AC, Shuford JA, Skaggs TA, Stull MA, Threadgill DW, Akpalu Y, Zuelke K.
PMID: 34544043
Am J Trop Med Hyg. 2021 Sep 20; doi: 10.4269/ajtmh.21-0542. Epub 2021 Sep 20.

To better understand the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant lineage distribution in a college campus population, we carried out viral genome surveillance over a 7-week period from January to March 2021. Among the sequences were three...

Cite
Neuman BW, Brashear WA, Brun M, et al. Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants. Am J Trop Med Hyg. 2021;doi: 10.4269/ajtmh.21-0542.
Neuman, B. W., Brashear, W. A., Brun, M., Chaki, S. P., Fischer, R. S. B., Guidry, S. J., Hill, J. E., Hillhouse, A. E., Johnson, C. D., Kahl-McDonagh, M. M., Metz, R. P., Rice-Ficht, A. C., Shuford, J. A., Skaggs, T. A., Stull, M. A., Threadgill, D. W., Akpalu, Y., & Zuelke, K. (2021). Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants. The American journal of tropical medicine and hygiene, . https://doi.org/10.4269/ajtmh.21-0542
Neuman, Benjamin W, et al. "Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants." The American journal of tropical medicine and hygiene vol. (2021). doi: https://doi.org/10.4269/ajtmh.21-0542
Neuman BW, Brashear WA, Brun M, Chaki SP, Fischer RSB, Guidry SJ, Hill JE, Hillhouse AE, Johnson CD, Kahl-McDonagh MM, Metz RP, Rice-Ficht AC, Shuford JA, Skaggs TA, Stull MA, Threadgill DW, Akpalu Y, Zuelke K. Case Report: Paucisymptomatic College-Age Population as a Reservoir for Potentially Neutralization-Resistant Severe Acute Respiratory Syndrome Coronavirus 2 Variants. Am J Trop Med Hyg. 2021 Sep 20; doi: 10.4269/ajtmh.21-0542. Epub 2021 Sep 20. PMID: 34544043; PMCID: PMC8592217.
Copy Download .nbib Format: NLM
Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis.

Frontiers in neurology

Bonakdarpour B, McFadden A, Zlotkowski S, Huang D, Shaker M, Shibata B, Haben W, Brashear C, Sandoval A, Breitenbach C, Rodriguez C, Viamille J, Porter M, Galic K, Schaeve M, Thatcher D, Takarabe C.
PMID: 34966344
Front Neurol. 2021 Dec 13;12:749782. doi: 10.3389/fneur.2021.749782. eCollection 2021.

Strict precautions during the COVID-19 pandemic left patients isolated during already stressful hospital stays. Research indicates that listening to music recruits regions in the brain involved with social interaction and reduces feelings of loneliness. We formed a team of...

Cite
Bonakdarpour B, McFadden A, Zlotkowski S, et al. Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis. Front Neurol. 2021;12:749782doi: 10.3389/fneur.2021.749782.
Bonakdarpour, B., McFadden, A., Zlotkowski, S., Huang, D., Shaker, M., Shibata, B., Haben, W., Brashear, C., Sandoval, A., Breitenbach, C., Rodriguez, C., Viamille, J., Porter, M., Galic, K., Schaeve, M., Thatcher, D., & Takarabe, C. (2021). Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis. Frontiers in neurology, 12749782. https://doi.org/10.3389/fneur.2021.749782
Bonakdarpour, Borna, et al. "Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis." Frontiers in neurology vol. 12 (2021): 749782. doi: https://doi.org/10.3389/fneur.2021.749782
Bonakdarpour B, McFadden A, Zlotkowski S, Huang D, Shaker M, Shibata B, Haben W, Brashear C, Sandoval A, Breitenbach C, Rodriguez C, Viamille J, Porter M, Galic K, Schaeve M, Thatcher D, Takarabe C. Neurology Telemusic Program at the Time of the COVID-19 Pandemic: Turning Hospital Time Into Aesthetic Time During Crisis. Front Neurol. 2021 Dec 13;12:749782. doi: 10.3389/fneur.2021.749782. eCollection 2021. PMID: 34966344; PMCID: PMC8710443.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 88 entries